[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Antidiabetic Thiazolidinediones Market Research Report 2017

January 2017 | 98 pages | ID: CD00D6D0E76EN
QYResearch

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Antidiabetic Thiazolidinediones

Revenue, means the sales value of Antidiabetic Thiazolidinediones

This report studies Antidiabetic Thiazolidinediones in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
  • Sanofi
  • Takeda Pharmaceuticals
  • Eli Lilly
  • Merck & Co.
  • Novo Nordisk
  • Bristol-Myers Squibb
  • Pfizer
  • AstraZeneca
  • GlaxoSmithKline
  • Boehringer Ingelheim
Market Segment by Regions (provinces), covering
  • South China
  • East China
  • Southwest China
  • Northeast China
  • North China
  • Central China
  • Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
  • Rosiglitazone
  • Pioglitazone
Split by Application, this report focuses on consumption, market share and growth rate of Antidiabetic Thiazolidinediones in each application, can be divided into
  • Hospital
  • Clinic
China Antidiabetic Thiazolidinediones Market Research Report 2017

1 ANTIDIABETIC THIAZOLIDINEDIONES MARKET OVERVIEW

1.1 Product Overview and Scope of Antidiabetic Thiazolidinediones
1.2 Antidiabetic Thiazolidinediones Segment by Type
  1.2.1 China Production Market Share of Antidiabetic Thiazolidinediones Type in 2015
  1.2.2 Rosiglitazone
  1.2.3 Pioglitazone
1.3 Applications of Antidiabetic Thiazolidinediones
  1.3.1 Antidiabetic Thiazolidinediones Consumption Market Share by Application in 2015
  1.3.2 Hospital
  1.3.3 Clinic
1.4 China Market Size (Value) of Antidiabetic Thiazolidinediones (2011-2021)
1.5 China Antidiabetic Thiazolidinediones Status and Outlook
1.6 Government Policies

2 CHINA ANTIDIABETIC THIAZOLIDINEDIONES MARKET COMPETITION BY MANUFACTURERS

2.1 China Antidiabetic Thiazolidinediones Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Antidiabetic Thiazolidinediones Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Antidiabetic Thiazolidinediones Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Antidiabetic Thiazolidinediones Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antidiabetic Thiazolidinediones Market Competitive Situation and Trends
  2.5.1 Antidiabetic Thiazolidinediones Market Concentration Rate
  2.5.2 Antidiabetic Thiazolidinediones Market Share of Top 3 and Top 5 Manufacturers

3 CHINA ANTIDIABETIC THIAZOLIDINEDIONES MANUFACTURERS PROFILES/ANALYSIS

3.1 Sanofi
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    3.1.2.1 Rosiglitazone
    3.1.2.2 Pioglitazone
  3.1.3 Sanofi Antidiabetic Thiazolidinediones Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 Takeda Pharmaceuticals
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    3.2.2.1 Rosiglitazone
    3.2.2.2 Pioglitazone
  3.2.3 Takeda Pharmaceuticals 98 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Eli Lilly
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    3.3.2.1 Rosiglitazone
    3.3.2.2 Pioglitazone
  3.3.3 Eli Lilly 111 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 Merck & Co.
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    3.4.2.1 Rosiglitazone
    3.4.2.2 Pioglitazone
  3.4.3 Merck & Co. Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 Novo Nordisk
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    3.5.2.1 Rosiglitazone
    3.5.2.2 Pioglitazone
  3.5.3 Novo Nordisk Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 Bristol-Myers Squibb
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    3.6.2.1 Rosiglitazone
    3.6.2.2 Pioglitazone
  3.6.3 Bristol-Myers Squibb Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview
3.7 Pfizer
  3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.7.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    3.7.2.1 Rosiglitazone
    3.7.2.2 Pioglitazone
  3.7.3 Pfizer Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.7.4 Main Business/Business Overview
3.8 AstraZeneca
  3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.8.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    3.8.2.1 Rosiglitazone
    3.8.2.2 Pioglitazone
  3.8.3 AstraZeneca Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.8.4 Main Business/Business Overview
3.9 GlaxoSmithKline
  3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.9.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    3.9.2.1 Rosiglitazone
    3.9.2.2 Pioglitazone
  3.9.3 GlaxoSmithKline Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.9.4 Main Business/Business Overview
3.10 Boehringer Ingelheim
  3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.10.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    3.10.2.1 Rosiglitazone
    3.10.2.2 Pioglitazone
  3.10.3 Boehringer Ingelheim Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.10.4 Main Business/Business Overview

4 CHINA ANTIDIABETIC THIAZOLIDINEDIONES CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China Antidiabetic Thiazolidinediones Capacity, Production and Growth (2011-2016)
4.2 China Antidiabetic Thiazolidinediones Revenue and Growth (2011-2016)
4.3 China Antidiabetic Thiazolidinediones Production, Consumption, Export and Import (2011-2016)

5 CHINA ANTIDIABETIC THIAZOLIDINEDIONES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Antidiabetic Thiazolidinediones Production and Market Share by Type (2011-2016)
5.2 China Antidiabetic Thiazolidinediones Revenue and Market Share by Type (2011-2016)
5.3 China Antidiabetic Thiazolidinediones Price by Type (2011-2016)
5.4 China Antidiabetic Thiazolidinediones Production Growth by Type (2011-2016)

6 CHINA ANTIDIABETIC THIAZOLIDINEDIONES MARKET ANALYSIS BY APPLICATION

6.1 China Antidiabetic Thiazolidinediones Consumption and Market Share by Application (2011-2016)
6.2 China Antidiabetic Thiazolidinediones Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 CHINAANTIDIABETIC THIAZOLIDINEDIONES MARKET ANALYSIS BY REGIONS (PROVINCES)

7.1 China Antidiabetic Thiazolidinediones Production, Production Value and Price by Regions (Provinces)(2011-2016)
  7.1.1 China Antidiabetic Thiazolidinediones Production and Market Share by Regions (Provinces)(2011-2016)
  7.1.2 China Antidiabetic Thiazolidinediones Production Value and Market Share by Regions (Provinces)(2011-2016)
  7.1.3 China Antidiabetic Thiazolidinediones Sales Price by Regions (Provinces)(2011-2016)
7.2 China Antidiabetic Thiazolidinediones Consumption by Regions (Provinces)(2011-2016)
7.3 China Antidiabetic Thiazolidinediones Production, Consumption, Export and Import (2011-2016)

8 ANTIDIABETIC THIAZOLIDINEDIONES MANUFACTURING COST ANALYSIS

8.1 Antidiabetic Thiazolidinediones Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Antidiabetic Thiazolidinediones

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Antidiabetic Thiazolidinediones Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Antidiabetic Thiazolidinediones Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 CHINA ANTIDIABETIC THIAZOLIDINEDIONES MARKET FORECAST (2016-2021)

12.1 China Antidiabetic Thiazolidinediones Capacity, Production, Revenue Forecast (2016-2021)
12.2 China Antidiabetic Thiazolidinediones Production, Import, Export and Consumption Forecast (2016-2021)
12.3 China Antidiabetic Thiazolidinediones Production Forecast by Type (2016-2021)
12.4 China Antidiabetic Thiazolidinediones Consumption Forecast by Application (2016-2021)
12.5 China Antidiabetic Thiazolidinediones Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
  12.5.1 China Antidiabetic Thiazolidinediones Production Forecast by Regions (Provinces)(2016-2021)
  12.5.2 China Antidiabetic Thiazolidinediones Consumption Forecast by Regions (Provinces)(2016-2021)
  12.5.3 China Antidiabetic Thiazolidinediones Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.6 Antidiabetic Thiazolidinediones Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Antidiabetic Thiazolidinediones
Figure China Production Market Share of Antidiabetic Thiazolidinediones by Type in 2015
Figure Product Picture of Rosiglitazone
Table Major Manufacturers of Rosiglitazone
Figure Product Picture of Pioglitazone
Table Major Manufacturers of Pioglitazone
Table Antidiabetic Thiazolidinediones Consumption Market Share by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure China Antidiabetic Thiazolidinediones Revenue (Million USD) and Growth Rate (2011-2021)
Table China Antidiabetic Thiazolidinediones Capacity of Key Manufacturers (2015 and 2016)
Table China Antidiabetic Thiazolidinediones Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Antidiabetic Thiazolidinediones Capacity of Key Manufacturers in 2015
Figure China Antidiabetic Thiazolidinediones Capacity of Key Manufacturers in 2016
Table China Antidiabetic Thiazolidinediones Production of Key Manufacturers (2015 and 2016)
Table China Antidiabetic Thiazolidinediones Production Share by Manufacturers (2015 and 2016)
Figure 2015 Antidiabetic Thiazolidinediones Production Share by Manufacturers
Figure 2016 Antidiabetic Thiazolidinediones Production Share by Manufacturers
Table China Antidiabetic Thiazolidinediones Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Antidiabetic Thiazolidinediones Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Antidiabetic Thiazolidinediones Revenue Share by Manufacturers
Table 2016 China Antidiabetic Thiazolidinediones Revenue Share by Manufacturers
Table China Market Antidiabetic Thiazolidinediones Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Antidiabetic Thiazolidinediones Average Price of Key Manufacturers in 2015
Table Manufacturers Antidiabetic Thiazolidinediones Manufacturing Base Distribution and Sales Area
Table Manufacturers Antidiabetic Thiazolidinediones Product Type
Figure Antidiabetic Thiazolidinediones Market Share of Top 3 Manufacturers
Figure Antidiabetic Thiazolidinediones Market Share of Top 5 Manufacturers
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Antidiabetic Thiazolidinediones Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Antidiabetic Thiazolidinediones Market Share (2011-2016)
Table Takeda Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Market Share (2011-2016)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Antidiabetic Thiazolidinediones Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Antidiabetic Thiazolidinediones Market Share (2011-2016)
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Antidiabetic Thiazolidinediones Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co. Antidiabetic Thiazolidinediones Market Share (2011-2016)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Antidiabetic Thiazolidinediones Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Antidiabetic Thiazolidinediones Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Antidiabetic Thiazolidinediones Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Antidiabetic Thiazolidinediones Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Antidiabetic Thiazolidinediones Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Antidiabetic Thiazolidinediones Market Share (2011-2016)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Antidiabetic Thiazolidinediones Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Antidiabetic Thiazolidinediones Market Share (2011-2016)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Antidiabetic Thiazolidinediones Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Antidiabetic Thiazolidinediones Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Antidiabetic Thiazolidinediones Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Antidiabetic Thiazolidinediones Market Share (2011-2016)
Figure China Antidiabetic Thiazolidinediones Capacity, Production and Growth (2011-2016)
Figure China Antidiabetic Thiazolidinediones Revenue (Million USD) and Growth (2011-2016)
Table China Antidiabetic Thiazolidinediones Production, Consumption, Export and Import (2011-2016)
Table China Antidiabetic Thiazolidinediones Production by Type (2011-2016)
Table China Antidiabetic Thiazolidinediones Production Share by Type (2011-2016)
Figure Production Market Share of Antidiabetic Thiazolidinediones by Type (2011-2016)
Figure 2015 Production Market Share of Antidiabetic Thiazolidinediones by Type
Table China Antidiabetic Thiazolidinediones Revenue by Type (2011-2016)
Table China Antidiabetic Thiazolidinediones Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Antidiabetic Thiazolidinediones by Type (2011-2016)
Figure 2015 Revenue Market Share of Antidiabetic Thiazolidinediones by Type
Table China Antidiabetic Thiazolidinediones Price by Type (2011-2016)
Figure China Antidiabetic Thiazolidinediones Production Growth by Type (2011-2016)
Table China Antidiabetic Thiazolidinediones Consumption by Application (2011-2016)
Table China Antidiabetic Thiazolidinediones Consumption Market Share by Application (2011-2016)
Figure China Antidiabetic Thiazolidinediones Consumption Market Share by Application in 2015
Table China Antidiabetic Thiazolidinediones Consumption Growth Rate by Application (2011-2016)
Figure China Antidiabetic Thiazolidinediones Consumption Growth Rate by Application (2011-2016)
Table China Antidiabetic Thiazolidinediones Production by Regions (Provinces)(2011-2016)
Table China Antidiabetic Thiazolidinediones Production Market Share by Regions (Provinces)(2011-2016)
Table China Antidiabetic Thiazolidinediones Production Value by Regions (Provinces)(2011-2016)
Table China Antidiabetic Thiazolidinediones Production Value Market Share by Regions (Provinces)(2011-2016)
Table China Antidiabetic Thiazolidinediones Sales Price by Regions (Provinces)(2011-2016)
Table China Antidiabetic Thiazolidinediones Consumption by Regions (Provinces)(2011-2016)
Table China Antidiabetic Thiazolidinediones Consumption Market Share by Regions (Provinces)(2011-2016)
Table China Antidiabetic Thiazolidinediones Production, Consumption, Export and Import (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidiabetic Thiazolidinediones
Figure Manufacturing Process Analysis of Antidiabetic Thiazolidinediones
Figure Antidiabetic Thiazolidinediones Industrial Chain Analysis
Table Raw Materials Sources of Antidiabetic Thiazolidinediones Major Manufacturers in 2015
Table Major Buyers of Antidiabetic Thiazolidinediones
Table Distributors/Traders List
Figure China Antidiabetic Thiazolidinediones Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Antidiabetic Thiazolidinediones Revenue and Growth Rate Forecast (2016-2021)
Table China Antidiabetic Thiazolidinediones Production, Import, Export and Consumption Forecast (2016-2021)
Table China Antidiabetic Thiazolidinediones Production Forecast by Type (2016-2021)
Table China Antidiabetic Thiazolidinediones Consumption Forecast by Application (2016-2021)
Table China Antidiabetic Thiazolidinediones Production Forecast by Regions (Provinces)(2016-2021)
Table China Antidiabetic Thiazolidinediones Consumption Forecast by Regions (Provinces)(2016-2021)
Table China Antidiabetic Thiazolidinediones Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)


More Publications